Novel Mutations in ACVR1 Result in Atypical Features in Two Fibrodysplasia Ossificans Progressiva Patients
Kirsten A. Petrie, Wen Hwa Lee, Alex N. Bullock et al. · 2009
Read Novel Mutations in ACVR1 Result in Atypical Features in Two Fibrodysplasia Ossificans Progressiva Patients by Kirsten A. Petrie, Wen Hwa Lee, Alex N. Bullock et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005005.txt.
Introduction
Fibrodysplasia ossificans progressiva is a rare inherited disease. Muscle, ligament and tendon slowly turn to bone. Most cases come from one classic mutation in the gene ACVR1. Kirsten Petrie and colleagues reported exceptions in PLOS ONE in 2009. They studied two patients with unusual features. Both carried new mutations in ACVR1.
The new variants expand the disease's genetic picture. They show the classic mutation is not the only route. Atypical cases can now be recognized and diagnosed. The finding helps doctors who meet puzzling presentations. It also teaches more about how ACVR1 normally controls bone growth. That control is exactly what fails in this cruel disease.
Catalog record
| CREATOR | Kirsten A. Petrie, Wen Hwa Lee, Alex N. Bullock et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 18 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005005
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Novel Mutations in ACVR1 Result in Atypical Features in Two Fibrodysplasia Ossificans Progressiva Patients Authors: Kirsten A. Petrie, Wen Hwa Lee, Alex N. Bullock, Jenny J. Pointon, Roger Smith, R. Graham G. Russell, Matthew A. Brown, B. Paul Wordsworth, James T. Triffitt Published: 2009, PLOS ONE DOI: 10.1371/journal.pone.0005005 ABSTRACT Fibrodysplasia Ossificans Progressiva (FOP) is a rare, heritable condition typified by progression of extensive ossification within skeletal muscle, ligament and tendon together with defects in skeletal development. The condition is easily diagnosed by the presence of shortened great toes and there is severe advancement of disability with age. FOP has been shown to result from a point mutation (c.617G>A) in the ACVR1 gene in almost all patients reported. Very recently two other mutations have been described in three FOP patients. We present here evidence for two further unique mutations (c.605G>T and c.983G>A) in this gene in two FOP patients with some atypical digit abnormalities and other clinical features. The observation of disparate missense mutations mapped to the GS and kinase domains of the protein supports the disease model of mild kinase activation and provides a potential rationale for phenotypic variation. INTRODUCTION Fibrodysplasia Ossificans Progressiva (FOP) is a rare, autosomal dominant disease with complete penetrance involving the progressive ossification of the skeletal muscles, fasciae, tendons and ligaments. Smooth muscle and cardiac muscles remain unaffected. Due to low reproductive fitness the condition is mainly a result of spontaneous new mutations and it has a prevalence of approximately one in two million individuals worldwide. FOP shows no geographic, ethnic, racial or gender predisposition [1] . Individuals with FOP appear normal at birth except for great toe abnormalities; these being short, deviated and later monophalangic. Extensive fusion of the lateral masses of the cervical vertebrae is often seen with hypoplasia of the vertebral bodies. Femoral necks are abnormally wide and there may be true bone exostoses additional to muscle ossification with short malformed thumbs being less common [2] , [3] . Following periodic acute episodes of mysositis, endochondral ossification of striated muscles generally begins in the occipital, cervical and upper paraspinal muscles and later affects most muscles around the major joints. Minor trauma or viral illnesses can initiate acute inflammatory mysositic episodes leading to progressive heterotopic ossification, which is amplified by surgical intervention or removal. The phenotype of FOP is affected by both genetic and environmental factors with postnatal heterotopic ossification varying with life history and environmental exposure [4] . Ossification occurs progressively over the course of a lifetime in an inevitable episodic and unpredictable manner with most patients being confined to a wheelchair by the third decade of life and requiring lifelong care. Recently the genetic cause of FOP was discovered within the ACVR1 gene, which encodes a type I bone morphogenetic protein (BMP) transmembrane receptor [5] . A single point mutation (c.617G>A) was identified in all FOP patients studied. This non-synonymous mutation causes an Arg206His amino acid substitution within the GS (glycine-serine rich) domain of the ACVR1 protein, and has been confirmed by our further work and also by others [6] , [7] . Type I receptors such as ACVR1 are normally inactive until binding of extracellular BMP stimulates their phosphorylation by type II receptors within the GS domain. This activates the type I protein to recruit and phosphorylate Smad signalling molecules within the cell that subsequently cause gene transcription or repression. The GS domain is also negatively regulated through the binding of FKBP12, which provides a mechanism to buffer the overall signal in the cell [8] . The switch between the inactive and active states has been illustrated by crystal structures of the type I TGF-beta receptor kinase domain as well as its complex with FKBP12 [9] , [10] . It has been observed that the Arg206His mutation causes the ACVR1 protein to be mildly constitutively active [11] . Since the mutation occurs in the activating GS domain it has been suggested that this promotes a shift in the absence of BMP towards the active kinase structure causing over-activation of ACVR1 and subsequent R-Smad signalling cascades [5] , [12] . Recently other ACVR1 mutations have been reported in three FOP patients. A Japanese man with FOP has been reported with an ACVR1 mutation, c.1067G>A resulting in a Gly356Asp amino-acid change in the protein kinase domain [13] . In two Italian patients, a novel mutation c.774G>C, leading to the Arg258Ser substitution in the kinase domain of the ACVR1 receptor was seen. In a three-dimensional model of the protein structure, Arg258 maps in close proximity to the GS domain [14] . Here we report two patients with expression of the major characteristics that define FOP, but with some atypical features, that both lack the typical, specific c.617G>A mutation and the other recently reported mutations but present two different and separate coding mutations in ACVR1 . METHODS Patient 1 is female and was diagnosed clinically with FOP in 2003 aged 14 years. The first presentation was with a painful bony lump over her right scapula after a fall and clinical examination showed that there was only one short great toe with the other normal. Subsequently she developed multiple tender bony swellings, and the detection of toe abnormality confirmed the diagnosis. Her right shoulder was fixed in internal rotation. Fixed flexion deformities of both elbows were present. Her lumbar spinal movements were restricted. The patient continued to have frequent flares of the condition with increased inflammatory lesions over her shoulder joints, neck, and jaw and fusion of the neck within 6 months of clinical presentation. This progressive formation of lesions which later ossify is characteristic to FOP. However, the relatively late age of onset is unusual and the malformation of only one great toe has yet to be documented in another patient. Patient 2 is a 52 year old female with FOP whose clinical features were first reported in 1976 [15] and subsequently reviewed later [15] , [16] . Severe reduction deformities in all digits were noted at birth. Her first presentation of the disease was with lumps, usually painful, on the occiput. By 6 years the patient had a stiff spine and shoulders. By 14 years both elbows and the right hip showed ectopic ossification. At 18 years the left hip showed ectopic ossification and at 20 years there was ossification around the jaw after dental extraction. At 26 years the patient had complete spinal fixation, the shoulders were fixed in adduction, the elbows fixed in flexion, hip movement restricted and fixed in slight flexion and the jaw gape was 0.3cm. She showed mild cognitive impairment. In addition, there was diffuse scalp hair thinning beginning at 14 years of age. GENETIC ANALYSES Patient samples. Blood samples were collected from patients and family members and from normal controls with informed consent. Lymphoblastoid cell lines were a generous gift from Professor J M Connor, Glasgow,UK. DNA Isolation. Genomic DNA was isolated from EBV-transformed cell lines or from peripheral blood samples using the FlexigeneTM Kit (Qiagen Ltd, UK) according to the manufacturer's instructions. The resulting DNA was resuspended in the elution buffer supplied in the kit. Identification of mutations. PCR primers (MWG Biotech AG, Edersberg, Germany) were designed to amplify exon 6 of ACVR1 which contains the c.617G>A